HC
MRK icon

Hamilton Capital’s Merck MRK Stock Holding History

Hamilton Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$768K Buy
6,388
+452
+8% +$52.2K 0.04% 56
2025
Q4 		$625K Buy
+5,936
New +$557K 0.03% 59
2025
Q2 		$387K Sell
4,883
-1,548
-24% -$123K 0.02% 81
2025
Q1 		$577K Buy
6,431
+1,120
+21% +$105K 0.03% 54
2024
Q4 		$528K Buy
5,311
+803
+18% +$82.8K 0.04% 57
2024
Q3 		$461K Buy
4,508
+279
+7% +$33.1K 0.03% 62
2024
Q2 		$524K Sell
4,229
-1,830
-30% -$236K 0.04% 48
2024
Q1 		$799K Sell
6,059
-274
-4% -$33.8K 0.06% 45
2023
Q4 		$690K Sell
6,333
-760
-11% -$78.9K 0.06% 50
2023
Q3 		$730K Sell
7,093
-16
-0.2% -$1.73K 0.06% 42
2023
Q2 		$820K Sell
7,109
-173
-2% -$19.6K 0.06% 38
2023
Q1 		$775K Sell
7,282
-2,516
-26% -$272K 0.05% 32
2022
Q4 		$1.09M Buy
9,798
+4,812
+97% +$492K 0.07% 30
2022
Q3 		$429K Sell
4,986
-748
-13% -$66.8K 0.03% 42
2022
Q2 		$523K Buy
5,734
+61
+1% +$5.41K 0.03% 42
2022
Q1 		$465K Buy
5,673
+32
+0.6% +$2.52K 0.03% 53
2021
Q4 		$432K Buy
5,641
+1,064
+23% +$84.7K 0.03% 82
2021
Q3 		$344K Buy
4,577
+1,568
+52% +$119K 0.03% 52
2021
Q2 		$234K Buy
3,009
+61
+2% +$4.54K 0.02% 46
2021
Q1 		$217K Buy
2,948
+113
+4% +$8.34K 0.02% 46
2020
Q4 		$221K Sell
2,835
-173
-6% -$13.2K 0.04% 40
2020
Q3 		$238K Sell
3,008
-208
-6% -$16.3K 0.09% 29
2020
Q2 		$237K Sell
3,216
-25
-0.8% -$1.88K 0.09% 33
2020
Q1 		$238K Buy
3,241
+234
+8% +$18.4K 0.09% 26
2019
Q4 		$261K Buy
3,007
+430
+17% +$35.3K 0.11% 34
2019
Q3 		$207K Sell
2,577
-12,308
-83% -$986K 0.1% 27
2019
Q2 		$1.19M Buy
14,885
+12,230
+461% +$936K 0.41% 17
2019
Q1 		$211K Buy
+2,655
New +$199K 0.1% 33

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hamilton Capital's MRK Position: Q1 2026 in Review

Hamilton Capital increased its Merck (MRK) stake by 7.6% in Q1 2026, buying an estimated $52.2K and bringing the position to 6,388 shares worth $768K. The position accounts for 0.04% of the portfolio, ranked #56.

Hamilton Capital first reported a position in MRK in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.19M in Q2 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hamilton Capital held 6,388 shares of Merck worth $768K as of Q1 2026.
  • Hamilton Capital bought 452 Merck shares in Q1 2026, an estimated $52.2K.
  • Merck made up 0.04% of Hamilton Capital's portfolio in Q1 2026, its #56 holding.
  • Hamilton Capital first reported a position in Merck in Q1 2019 and has held it in 28 quarters since.
  • Hamilton Capital's Merck position peaked at $1.19M in Q2 2019.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hamilton Capital's 13F filing for Q1 2026, filed 15 May 2026.